NCT05527730 is a NA clinical trial of Comparison of PRO-FIT or SELF-FIT fitting in Hearing Loss, sponsored by Whisper.ai.

Who is sponsoring NCT05527730?

NCT05527730 is sponsored by Whisper.ai.

What drugs are being tested in NCT05527730?

Interventions in NCT05527730: Comparison of PRO-FIT or SELF-FIT fitting.

What condition does NCT05527730 study?

NCT05527730 studies Hearing Loss.

Is NCT05527730 still recruiting?

NCT05527730 is currently status unknown. Last updated 7 December 2022.

Last reviewed 2022-12-07 · How we verify

NCT05527730

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial Evaluating Outcomes of Self-Fit and Professionally Fit Hearing Aids

Status unknown NA Last updated 7 December 2022

What this trial tests

NA trial testing Comparison of PRO-FIT or SELF-FIT fitting in Hearing Loss in 80 participants. Status unknown.

Timeline

7 July 2022

Primary endpoint
10 December 2022

20 December 2022

Quick facts

Lead sponsor	Whisper.ai
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	80
Start date	7 July 2022
Primary completion	10 December 2022
Estimated completion	20 December 2022
Sites	1 location across United States

Drugs / interventions tested

Comparison of PRO-FIT or SELF-FIT fitting

Conditions studied

Hearing Loss — all drugs for Hearing Loss →

Sponsor

Whisper.ai

Who can join

Adults 18 to 80, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Approximately 48 million people in the United States have hearing loss or hearing difficulties in noisy environments. Whisper.ai Inc has previously brought to market a commercial hearing aid system that reduces background noise and amplifies voices and sounds of interest using its proprietary platform based on machine learning and artificial intelligence technologies. Whisper.ai Inc now seeks to bring to market a new hearing system that will incorporate a "self-fitting" capability. Self-fitting hearing aids have emerged in recent years as a potentially viable option to calibrate hearing aids to the needs of individual users without clinician intervention. The purpose of this project is to evaluate the efficiency and reliability of the fitting procedure and algorithms developed by Whisper.ai Inc. The study will be carried out using a randomized crossover design in two phases: in phase 1, subjects will be tested and a hearing aid will be fitted using conventional audiological standard procedures , and in phase 2, the subject will be tested and a hearing aid will be fitted using the results of the self-fitting algorithm. Objective, subjective, and behavioral responses will be gathered from a variety of hearing-related surveys and tests, and will be analyzed quantitatively to evaluate the efficiency and reliability of the self-fitting algorithm. The investigators expect the fitting results of the Whisper.ai self-fitting algorithm to be similar to those of standardized fitting procedures conducted by hearing professionals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hearing Loss

Currently open trials in the same condition.

NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III · Phase 1 · recruiting
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05527730 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Whisper.ai
Last refreshed: 7 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05527730.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing